No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Diagnostics & Research
Krsnaa Diagnostics Limited specializes in delivering a comprehensive range of diagnostic solutions. The company utilizes technology to provide services such as radiology, clinical pathology, and tele-radiology to diverse clients, including public and private healthcare facilities, medical colleges, and local community health centers. By December 31, 2020, its extensive network featured 1,801 diagnostic centers distributed across 13 Indian states. Established in 2010, the company maintains its headquarters in Pune, India.
krsnaadiagnostics.comNo one on the platform currently holds KRSNAA.NS.
No tracked institution reports a position in KRSNAA.NS as of their last filing.
No one on the platform has traded KRSNAA.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 6.4% | 7.6% | — | — | — | |
| Rev. Growth % | 7.8% | 14.3% | ||||
| Profit Margin % | 13.1% | 12.2% | -2.6% | |||
| Free Cash Flow Margin % | -12.2% | -11.8% | -12.3% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $9.6B | +22.6% | $49.17 | $46.19–$52.14 | — | 2 |
| 2028 | $11.2B | +16.2% | $61.13 | $45.82–$84.64 | — | 3 |
| 2029 | $12.0B | +7.2% | $38.70 | $38.23–$39.17 | — | 1 |
| 2030 | $13.6B | +13.3% | $47.30 | $46.72–$47.88 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-13 | $6.21 | $5.20 | -16.3% |
| 2026-05-25 | $2.45 | $9.65 | +293.9% |
| 2026-02-05 | $6.07 | $4.90 | -19.3% |
| 2025-11-07 | $7.53 | $7.50 | -0.4% |
| 2025-08-11 | $8.00 | $6.40 | -20.0% |
| 2025-05-12 | $6.40 | $6.60 | +3.1% |
| 2025-02-12 | $6.30 | $5.88 | -6.7% |
| 2024-10-25 | $8.00 |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| KRSNAA.NSKrsnaa Diagnostics Limited | $536.40 | -0.97% | $17.4B | — |
| ALEMBICLTD.NSAlembic Limited | $98.95 | -1.55% | $25.4B | — |
| DRAGARWQ.BODr. Agarwal's Eye Hospital Limited | $5278.65 | +2.77% | $25.5B | — |
| IOLCP.BOIOL Chemicals and Pharmaceuticals Limited | $193.65 | +7.91% | $56.9B | — |
| IOLCP.NSIOL Chemicals and Pharmaceuticals Limited |
| $5.92 |
| -26.0% |
| $194.57 |
| +8.38% |
| $57.1B |
| — |
| MOREPENLAB.BOMorepen Laboratories Limited | $114.60 | +7.86% | $62.8B | — |
| MOREPENLAB.NSMorepen Laboratories Limited | $114.73 | +8.01% | $62.9B | — |
Source: Financial Modeling Prep · peers by sector/industry